Miyakoshi J, Yoshida T, Kashima J, Shirasawa M, et al. Clinical significance of inter-assay discrepancy in PD-L1 evaluation for the efficacy of pembrolizumab in advanced NSCLC with high PD-L1 expression. Lung Cancer 2024;191:107788.
PMID: 38593478